Lantheus Holdings, Inc.

LNTHSEC EDGAR

In Vitro & In Vivo Diagnostic Substances(DE)CIK: 1521036

Revenue (Latest FY)

$1.3B

Net Income (Latest FY)

$326.7M

Industry

In Vitro & In Vivo Diagnostic Substances

Recent Filings

Company Details

CIK1521036

Fiscal Year End1231

CategoryLarge accelerated filer

StateDE

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)